gadoversetamide

Action and Spectrum

Drug Interaction

Adverse Reaction

Adverse drug reactions  

Frequency Defined  

1-10%   

Diarrhea (1.9%)  

Abdominal pain (1.8%)  

Paresthesia (2.2%)  

Headache (9.4%)  

Back pain (1%)  

Dyspepsia (1%)  

Vasodilation (6.4%)  

Rhinitis (2%)  

Injection site reaction (2%)  

Dizziness (3.7%)  

Nausea (3.2%)  

<1%  

Amblyopia  

Dry skin  

Dystonia  

Flatulence  

Anorexia  

Cough  

Seizures  

Diplopia  

Black Box Warning

Contraindication / Caution

Pregnancy / Lactation

Pregnancy warnings:     

Pregnancy Category: C  

Lactation:  

Excreted into human milk is unknown  

Pregnancy Categories:        

Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.   

Category B: there was no evidence of risk to the fetus in animal studies, and there were no enough studies on pregnant women.  

Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.    

Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.    

Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.    

Category N: There is no data available for the drug under this category

Pharmacology

Adminstartion

Patient Information Leaflet

Patient Information Leaflet    

Generic Name: gadoversetamide    

Why do we use gadoversetamide?  

gadoversetamide is an magnetic resonance imaging contrast media used for CNS/Liver MRI (Magnetic Resonance Imaging)